tropics-02: sacituzumab govitecan in hr /her- breast cancer
Published 1 year ago • 326 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:49
final os analysis of sacituzumab govitecan in tropics-02
-
4:38
2nd interim analysis of os from tropics-02: sg in hr /her2- breast cancer
-
5:07
tropics-02: sacituzumab govetican improves pfs versus physicians choice for hr /her2- mbc
-
1:34
sacituzumab govitecan effective for hr metastatic breast cancer regardless of trop-2 status
-
2:58
#esmo22 highlights on sacituzumab govitecan in hr /her2- metastatic breast cancer: tropics-02
-
2:57
efficacy of sacituzumab govitecan in muc by trop-2 expression
-
4:42
tropics-02 shows sacituzumab govitecan os benefit in hr , her2– advanced breast cancer | hope rugo
-
2:16
efficacy of sacituzumab govitecan by trop-2 expression in patients with muc
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
1:00
therapeutic strategies to maximize sensitivity to endocrine therapy in breast cancer
-
3:59
sacituzumab govitecan for treatment-refractory metastatic breast cancer
-
1:13
phase iii tropics-04 trial: sacituzumab govitecan vs treatment of choice in advanced muc
-
17:31
tropics-02 data presented at sabcs 2023: implications for the hr breast cancer treatment paradigm
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
7:26
sacituzumab govitecan increases pfs for hr /her2‐ advanced breast cancer patients
-
3:59
sacituzumab govitecan increases pfs for hr /her2- metastatic breast cancer
-
5:37
metastatic breast cancer at esmo 2022: tropics02, monarch 3 and synergy
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients